Our Pricing

Published on: June 03, 2026

When you buy weight loss injections UK online through Cured Pharmacy, you access the same MHRA-licensed medications used by the NHS—without the lengthy waiting lists. Our UK-registered clinical team provides free consultations in under three minutes, with transparent upfront pricing and guaranteed discreet delivery across the United Kingdom.

How GLP-1 Weight Loss Injections Work

Weight loss injections prescribed in the UK belong to a class of medications called GLP-1 receptor agonists. These treatments mimic glucagon-like peptide-1, a natural hormone your body produces after eating that regulates appetite, slows gastric emptying, and influences blood sugar control [1].

Mounjaro (tirzepatide) represents the latest advancement in this field as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, tirzepatide produces superior weight reduction compared to single-pathway alternatives. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 22.5% over 72 weeks on the highest dose—substantially greater than results seen with semaglutide-based treatments [1][2].

Wegovy (semaglutide) and Saxenda (liraglutide) work through GLP-1 receptor activation alone. Clinical trials demonstrate that semaglutide produces an average weight loss of 14.9% over 68 weeks, whilst liraglutide achieves approximately 8% reduction over 56 weeks [2][3]. All three medications require subcutaneous injection and are available through Cured Pharmacy following clinical assessment by a UK prescriber.

Mounjaro, Wegovy, and Saxenda: Comparing Your Options

When comparing weight loss injections available through UK pharmacies, three MHRA-licensed options dominate: Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide). Each offers distinct advantages depending on your clinical profile and lifestyle preferences.

Mounjaro's dual-receptor mechanism produces the highest average weight reduction in clinical trials, making it particularly suitable for patients with significant weight to lose or those who have not achieved adequate results with other GLP-1 treatments. Wegovy offers robust efficacy with extensive real-world safety data, whilst Saxenda's daily dosing allows for more granular dose titration. At Cured Pharmacy, Mounjaro starts from £135.00 following prescriber approval, with competitive UK pricing across all three options.

Injection Frequency and Administration

Mounjaro and Wegovy are both administered once weekly using pre-filled KwikPen or FlexTouch devices, making them convenient for patients with busy schedules. Saxenda requires daily injection, which some patients find more manageable for dose adjustment but others consider less convenient. All three medications use small-gauge needles designed for subcutaneous injection into the abdomen, thigh, or upper arm.

Your UK prescriber will determine the appropriate starting dose based on your medical history, current medications, and weight loss goals. Doses are typically escalated gradually over several weeks to minimise gastrointestinal side effects—a standard protocol supported by NICE guidance for GLP-1 treatments [4].

Who Can Use Weight Loss Injections in the UK

Weight loss injections are prescription-only medications in the United Kingdom, requiring clinical assessment by a registered prescriber before dispensing. At Cured Pharmacy, our UK clinical team evaluates your medical history, current medications, and weight loss goals during a free online consultation that typically takes under three minutes to complete.

These treatments work most effectively when combined with lifestyle modifications including a reduced-calorie diet and increased physical activity. Clinical trials demonstrating the impressive weight reductions associated with tirzepatide and semaglutide all included dietary counselling and exercise recommendations as part of the intervention protocol [1][2]. Your prescriber will discuss realistic expectations and the importance of sustainable behaviour changes alongside pharmacological treatment.

Medical Eligibility Criteria

UK prescribers follow NICE guidance when assessing eligibility for GLP-1 weight loss treatments. Generally, these medications may be prescribed for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4].

Your online consultation will assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy. Patients with a history of pancreatitis require careful evaluation before starting GLP-1 therapy. All prescription decisions remain at the clinical discretion of your UK prescriber following comprehensive assessment.

Common Side Effects and How to Manage Them

Gastrointestinal side effects represent the most frequently reported adverse events with GLP-1 weight loss injections. Nausea, vomiting, diarrhoea, and constipation occur in 20-50% of patients during initial treatment, though symptoms typically diminish as your body adjusts to the medication [1][2][3].

To minimise these effects, UK prescribers use gradual dose escalation protocols—starting with lower doses and increasing every four weeks based on tolerability. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce gastrointestinal discomfort. If side effects persist or become severe, contact your prescriber to discuss dose adjustment or alternative treatment options.

Serious adverse events are rare but include potential risks of pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). The MHRA requires all GLP-1 products to carry warnings about thyroid C-cell tumours based on rodent studies, though no causal relationship has been established in humans [5]. Your Cured Pharmacy prescriber will review your complete medical history to identify any elevated risk factors before prescribing.

Accessing Weight Loss Injections Without NHS Waiting Lists

NHS waiting times for specialist weight management services can extend beyond 12 months in many UK regions, with strict eligibility criteria that exclude many patients who would benefit from GLP-1 therapy. Private access through registered online pharmacies provides a faster, more accessible route to evidence-based weight loss treatment whilst maintaining full regulatory compliance and clinical safety.

The consultation process at Cured Pharmacy takes under three minutes to complete online. You'll answer detailed questions about your medical history, current medications, allergies, and weight loss goals. A UK-registered prescriber reviews your assessment and, if appropriate, issues a prescription that our pharmacy team dispenses and ships with guaranteed discretion. This streamlined process eliminates multiple GP appointments and specialist referrals whilst ensuring you receive proper medical oversight.

Why Choose an Online Pharmacy for Weight Loss Treatment

Online pharmacies registered with the General Pharmaceutical Council offer a legitimate alternative pathway to prescription weight loss medications in the UK. At Cured Pharmacy (GPhC registration 9012511), you receive the same MHRA-licensed medications available through the NHS, dispensed by qualified pharmacists under the supervision of our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Our transparent pricing model shows exact costs before you begin your consultation—no hidden fees or surprise charges. We guarantee the lowest prices in the UK for genuine, licensed weight loss treatments, with discreet packaging and prompt delivery. Every prescription undergoes clinical review by UK-registered prescribers who assess your suitability according to the same professional standards applied in traditional healthcare settings.

Getting Started: Your Journey to Effective Weight Loss

Beginning weight loss injection therapy requires commitment to both the medication regimen and complementary lifestyle changes. Before starting your consultation at Cured Pharmacy, gather information about your current weight, height, any previous weight loss attempts, existing medical conditions, and a complete list of medications you currently take—including over-the-counter supplements.

Once your prescription is approved and dispensed, you'll receive detailed instructions for injection technique, storage requirements (these medications require refrigeration), and dose escalation schedules. Our pharmacy team remains available by phone on (+44) 116 4646009 to answer questions about administration, side effect management, or prescription refills. Regular follow-up assessments ensure your treatment remains safe and effective as you progress towards your weight loss goals.

What to Expect in Your First Month

During the initial four weeks of treatment, you'll use the lowest starter dose of your prescribed medication to allow your body to adjust. Most patients experience minimal weight loss during this titration phase—the primary goal is establishing tolerability rather than rapid weight reduction. Keep a symptom diary to track any side effects and discuss them with your prescriber at your first follow-up.

Significant weight loss typically becomes apparent from week 8 onwards as doses increase to therapeutic levels. Clinical trials show that maximum weight reduction occurs between 60-72 weeks of continuous treatment, with most patients achieving steady, sustainable losses of 1-2 pounds per week once established on their maintenance dose [1][2]. Patience and consistency remain essential for optimal outcomes.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle changes. Clinical trial data represents average outcomes and does not guarantee individual results.